#precisionderm search results
@azitrainc Announces Addition of MD Anderson Cancer Center as Clinical Site for Phase 1/2 Trial of ATR-04 Targeting EGFRi-Associated Skin Rash #ClinicalTrial #PrecisionMedicine #PrecisionDerm #biotech #CancerRash $AZTR ir.azitrainc.com/news-releases/…
Reminder that @azitrainc Cofounder and Chief Operating Officer, Travis Whitfill PhD MPH, delivered a virtual presentation at the H.C. Wainwright 27th Annual Global Investment Conference Registration info: journey.ct.events/view/d825c56c-… #biotech #HCWainwright #PrecisionDerm
@azitrainc to Present at the H.C. Wainwright 27th Annual Global Investment Conference - more details available here $AZTR ir.azitrainc.com/news-releases/…
More from this morning's announcement. See the full release here - #CancerRash #EGFRirash #PrecisionDerm #ClinicalTrials #Biotech $AZTR ir.azitrainc.com/news-releases/…
@azitrainc to Present at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference #biotech #JPM26 #precisionderm #raredisease ir.azitrainc.com/news-releases/…
@azitrainc Announces Q3 2025 Results and Provides Business Updates #biotech #PrecisionMedicine #PrecisionDerm #ClinicalTrials #NethertonSyndrome #EGFRiRash #CancerRash #IchthyosisVulgaris ir.azitrainc.com/news-releases/…
Here's Co-Founder & COO Travis Whitfill @twhitfill presenting at Biotech Showcase today. #Biotech #Raredisease #precisionderm $AZTR
ICYMI - @azitrainc COO Travis Whitfill with Zack's John Vandermosten this week #PrecisionDerm #NethertonSyndrome #CancerRash #Pipeline #Biotech $AZTR
Just out - @azitrainc COO & Co-Founder Travis Whitfill spoke with John Vandermosten of Zack - providing updates on the progress of our ATR-12 & ATR-04 programs. #PrecisionDerm #NethertonSyndrome #CancerRash #Pipeline #Biotech $AZTR youtube.com/watch?v=NrNvmU…
youtube.com
YouTube
Azitra's Pipeline Summer 2025
In case you missed it - @azitrainc presenting at Biotech Showcase in San Francisco Jan 13 #JPM26 #precisionderm #raredisease ir.azitrainc.com/news-releases/…
@azitrainc Announces First Patient Dosed in Phase 1/2 Trial for ATR-04 Program Targeting Oncology Patients with EGFRi-Associated Rash #CancerRash #EGFRirash #PrecisionDerm #ClinicalTrials #Biotech $AZTR ir.azitrainc.com/news-releases/…
Just out - @azitrainc COO & Co-Founder Travis Whitfill spoke with John Vandermosten of Zack - providing updates on the progress of our ATR-12 & ATR-04 programs. #PrecisionDerm #NethertonSyndrome #CancerRash #Pipeline #Biotech $AZTR youtube.com/watch?v=NrNvmU…
youtube.com
YouTube
Azitra's Pipeline Summer 2025
@azitrainc Announces Addition of MD Anderson Cancer Center as Clinical Site for Phase 1/2 Trial of ATR-04 Targeting EGFRi-Associated Skin Rash #ClinicalTrial #PrecisionMedicine #PrecisionDerm #biotech #CancerRash $AZTR ir.azitrainc.com/news-releases/…
Here's Co-Founder & COO Travis Whitfill @twhitfill presenting at Biotech Showcase today. #Biotech #Raredisease #precisionderm $AZTR
In case you missed it - @azitrainc presenting at Biotech Showcase in San Francisco Jan 13 #JPM26 #precisionderm #raredisease ir.azitrainc.com/news-releases/…
@azitrainc to Present at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference #biotech #JPM26 #precisionderm #raredisease ir.azitrainc.com/news-releases/…
@azitrainc Announces Q3 2025 Results and Provides Business Updates #biotech #PrecisionMedicine #PrecisionDerm #ClinicalTrials #NethertonSyndrome #EGFRiRash #CancerRash #IchthyosisVulgaris ir.azitrainc.com/news-releases/…
Reminder that @azitrainc Cofounder and Chief Operating Officer, Travis Whitfill PhD MPH, delivered a virtual presentation at the H.C. Wainwright 27th Annual Global Investment Conference Registration info: journey.ct.events/view/d825c56c-… #biotech #HCWainwright #PrecisionDerm
@azitrainc to Present at the H.C. Wainwright 27th Annual Global Investment Conference - more details available here $AZTR ir.azitrainc.com/news-releases/…
More from this morning's announcement. See the full release here - #CancerRash #EGFRirash #PrecisionDerm #ClinicalTrials #Biotech $AZTR ir.azitrainc.com/news-releases/…
@azitrainc Announces First Patient Dosed in Phase 1/2 Trial for ATR-04 Program Targeting Oncology Patients with EGFRi-Associated Rash #CancerRash #EGFRirash #PrecisionDerm #ClinicalTrials #Biotech $AZTR ir.azitrainc.com/news-releases/…
Francisco Salva, CEO of @azitrainc was interviewed in #ClinicalTrialVanguard last month. Here he discusses our unique approach #PrecisionDerm #Biotech #dermatology clinicaltrialvanguard.com/executiveinter…
Here's Co-Founder & COO Travis Whitfill @twhitfill presenting at Biotech Showcase today. #Biotech #Raredisease #precisionderm $AZTR
@azitrainc Announces Addition of MD Anderson Cancer Center as Clinical Site for Phase 1/2 Trial of ATR-04 Targeting EGFRi-Associated Skin Rash #ClinicalTrial #PrecisionMedicine #PrecisionDerm #biotech #CancerRash $AZTR ir.azitrainc.com/news-releases/…
In case you missed it - @azitrainc presenting at Biotech Showcase in San Francisco Jan 13 #JPM26 #precisionderm #raredisease ir.azitrainc.com/news-releases/…
@azitrainc Announces Presentation at ASCO 2025 Highlighting Clinical Trial Investigating ATR-04 for EGFRi-Associated Rash ir.azitrainc.com/news-releases/… #ASCO25 #PrecisionDerm #CancerRash #EGFRiRash #biotech
@azitrainc Announces Q3 2025 Results and Provides Business Updates #biotech #PrecisionMedicine #PrecisionDerm #ClinicalTrials #NethertonSyndrome #EGFRiRash #CancerRash #IchthyosisVulgaris ir.azitrainc.com/news-releases/…
Something went wrong.
Something went wrong.
United States Trends
- 1. Elvis N/A
- 2. Graceland N/A
- 3. The ACA N/A
- 4. Election Day N/A
- 5. Moana N/A
- 6. Solange N/A
- 7. Wonder Man N/A
- 8. Star Trek N/A
- 9. Kymora Johnson N/A
- 10. Double OT N/A
- 11. Homeward Bound N/A
- 12. Randy Bennett N/A
- 13. Obamacare N/A
- 14. Virginia N/A
- 15. Apple Maps N/A
- 16. #ENHYPEN_ALWAYS_7 N/A
- 17. Hannah Stuelke N/A
- 18. Affordable Care Act N/A
- 19. Maui N/A
- 20. Starfleet Academy N/A